TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2013

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.

Qaiser Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.